Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2000
05/10/2000EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
05/10/2000EP0998577A1 Conjugates of transporter peptides and nucleic acid analogs, and their use
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998495A1 Amyloid beta protein (globular assembly and uses thereof)
05/10/2000EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life
05/10/2000EP0998480A1 Nucleotide analog composition and synthesis method
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998474A1 Piperazine derivatives
05/10/2000EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0998465A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
05/10/2000EP0998464A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998459A2 Pyridine derivatives
05/10/2000EP0998455A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/10/2000EP0998306A1 Liposomal compositions for the delivery of nucleic acid catalysts
05/10/2000EP0998303A1 Biologically active materials
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998294A1 Ganglioside gm3 induced apoptosis of neural cells
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998291A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
05/10/2000EP0998290A1 Use of vitamin d compounds to prevent transplant rejection
05/10/2000EP0998289A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
05/10/2000EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/10/2000EP0998287A2 Use of levobupivacaine
05/10/2000EP0998286A2 Use of levobupivacaine
05/10/2000EP0998285A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/10/2000EP0998284A1 Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
05/10/2000EP0998283A1 Calcilytic compounds
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
05/10/2000EP0998279A1 Pharmaceutical injection solution containing taxol
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998277A1 Ophthalmic compositions for treating ocular hypertension
05/10/2000EP0998276A1 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0998274A2 Microdose therapy of vascular conditions by no donors
05/10/2000EP0998272A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/10/2000EP0998271A1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
05/10/2000EP0998268A1 Powder compositions of unilamellar liposomes
05/10/2000EP0998266A1 Microcrystalline cellulose: alginate pharmaceutical suspensions
05/10/2000EP0998264A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract
05/10/2000EP0998263A1 Pyrrolidine derivative hair growth compositions and uses
05/10/2000EP0998262A4 Isoflavonoids for treatment and prevention of aging skin and wrinkles
05/10/2000EP0998262A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles
05/10/2000EP0998251A2 Compositions and methods for inhibiting photoaging of skin
05/10/2000EP0925065A4 Water miscible erythromycin solutions
05/10/2000EP0820428B1 Terminal carboxy or tetrazole groups containing dialkyl ethers
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0763031B1 Piperazine derivatives as 5ht1a antagonists
05/10/2000EP0762879B1 Stereochemical wortmannin derivatives
05/10/2000EP0746313B1 Use of a composition comprising alpha hydroxy organic acid for the manufacture of a medicament for the treatment of small mouth ulcers
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0736004B1 (2,4-disulfophenyl) n-tertiary butyl nitrone, its salts, and their use as pharmaceutical radical trapping agents
05/10/2000EP0708647B1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor
05/10/2000EP0703781B1 Use of efaroxan and derivatives thereof for the preparation of a medicament for the treatment of parkinson's disease
05/10/2000EP0685234B1 Drug composition containing nucleic acid copolymer
05/10/2000EP0623019B1 Docosahexaenoic acid based drugs, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain, and preparation processes.
05/10/2000EP0602172B1 A method for treatment of patients with chronic liver disease
05/10/2000EP0563301B1 Cosmetic Process of Reducing the Rate of Mammalian Hair Growth
05/10/2000EP0494224B1 Use of steroid hormones in compositions for inducing t cell lymphokine production
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252807A Neoglycoproteins
05/10/2000CN1252805A Compositions for treating or preventing prostatic cancer
05/10/2000CN1252800A Farnesyltransferase inhibiting quinazolinones
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252797A Kodaistatins A, B, C and D, a process for their production and their use
05/10/2000CN1252794A Isoxazole derivatives
05/10/2000CN1252793A 4-aminoalkoxy-1H-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor D2 agonists
05/10/2000CN1252792A Process and intermediates for the preparation of 4'-trifluoromethyl-bipheyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
05/10/2000CN1252791A Arylsecochladiene derivatives
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252788A Process for preparing pharmaceutical compounds
05/10/2000CN1252728A Dolastatin-15 derivatives in combination with taxanes
05/10/2000CN1252727A Method and composition for treating sleep apnea
05/10/2000CN1252725A Analgesic combination
05/10/2000CN1252724A Method and rhytosterol composition for preventing alzheimer's disease
05/10/2000CN1252723A Use of 7 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis
05/10/2000CN1252722A Use of descarboethoxyloratadine for manfacture of medicament for treatment of urinary incontinence, motion sickness and vertigo
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252720A Gastric-retained pharmaceutical compositions
05/10/2000CN1252719A Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
05/10/2000CN1252718A Remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
05/10/2000CN1252716A Inhibitor of leaderless protein export
05/10/2000CN1252715A Preventives for ischemic heart diseases
05/10/2000CN1252714A Preventives for reconstriction
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252709A Confectionary compositions
05/10/2000CN1252708A Throat soothing compositions
05/10/2000CN1252705A Sustained analgesia achieved with buprenorphine
05/10/2000CN1252693A In-situ generation of zinc pyrithione
05/10/2000CN1252690A Fungicide active substance combinations
05/10/2000CN1252689A Combined tumor suppressor gene therapy and chemotherapy in treatment of neoplasms
05/10/2000CN1252415A Powdered rubber powder containing modified filler, its preparing method and its use
05/10/2000CN1252298A Hypoglycemic pharmaceutical and hypoglycemic food and the extraction method of its effective component
1 ... 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 6339 6340 6341 ... 7860